Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Bioprocessing Technology Market Size Forecast: How Big Could The Market Get By 2030?
The bioprocessing technology market has experienced significant expansion in recent years. Its valuation is predicted to rise from $71.39 billion in 2025 to $81.45 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.1%. This historical growth can be linked to the increasing demand for biologics production, the enlargement of biopharmaceutical manufacturing capacity, a wider adoption of cell culture technologies, greater investment in life sciences research, and improved access to bioprocessing consumables.
The bioprocessing technology market is set for significant expansion over the next few years. This market is projected to reach $139.77 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 14.5%. This projected growth during the forecast period is driven by several factors, including the escalating demand for biosimilars and recombinant proteins, the increasing integration of automation in biomanufacturing processes, the expansion of personalized medicine production, a heightened emphasis on optimizing processes, and the rising trend of outsourcing to CMOs. Key developments anticipated within this forecast period encompass the wider embrace of single-use bioprocessing systems, an increase in the utilization of automated cell expansion platforms, the expanding incorporation of advanced biologics safety testing, the proliferation of continuous bioprocessing methods, and a sharpened focus on achieving scalable biomanufacturing solutions.
Get A Free Sample Report With In-Depth Market Insights:
Bioprocessing Technology Market Demand Drivers: What’s Powering Industry Growth?
The escalating prevalence of chronic diseases is anticipated to advance the bioprocessing technology market. Chronic diseases are defined as prolonged health conditions lasting at least a year, often impacting daily activities, requiring continuous medical attention, or both. Bioprocessing technologies are crucial for developing therapeutic proteins, polysaccharides, vaccines, and diagnostics, all essential for managing chronic diseases. Consequently, a greater occurrence of these diseases will bolster the expansion of the bioprocessing technology market. For example, the World Health Organization, a Switzerland-based United Nations agency, stated in February 2024 that new cancer cases are expected to reach over 35 million by 2050, representing a 77% surge from the estimated 20 million cases in 2022. This projected rise in chronic diseases will therefore propel the growth of the bioprocessing technology market.
Bioprocessing Technology Market Segment Analysis: What Are The Core Market Categories?
The bioprocessing technology market covered in this report is segmented –
1) By Product: Biologics Safety Testing, Cell Culture, Cell Expansion, Cell Line Development, Flow Cytometry, Tangential Flow Filtration
2) By Application: Antibiotics, Biosimilars, Recombinant Proteins, Other Applications
3) By End Use: Biopharmaceutical Companies, Contract Manufacturing Organization, Academic Research Institutes, Food and Feed Industry, Contract Research Organization
Subsegments:
1) By Biologics Safety Testing: Endotoxin Testing, Sterility Testing, Viral Safety Testing
2) By Cell Culture: Mammalian Cell Culture, Microbial Cell Culture, Insect Cell Culture
3) By Cell Expansion: Manual Cell Expansion, Automated Cell Expansion
4) By Cell Line Development: Hybridoma Technology, Recombinant Cell Line Development
5) By Flow Cytometry: Cell Sorting, Cell Analysis
6) By Tangential Flow Filtration: Microfiltration, Ultrafiltration
Bioprocessing Technology Market Innovation Trends: What Developments Are Reshaping The Industry?
Major companies operating in the bioprocessing technology market are concentrating on developing bioprocessing solutions, such as bioprocessing platforms, to meet rising demands for enhanced yield and to maximize their profits within the market. A bioprocessing platform denotes a comprehensive system or collection of technologies and methods engineered for the efficient, large-scale processing of biological materials to generate biopharmaceuticals or other bioproducts. For instance, in October 2023, WuXi Biologics, a China-based contract research, development, and manufacturing organization, introduced WuXiUI, a high-productivity bioprocessing platform created to boost the productivity and quality of various mammalian cell lines and product modalities. WuXiUI leverages an ultra-intensified intermittent-perfusion fed-batch (UI-IPFB) strategy, which leads to a 3 to 6-fold increase in productivity compared to conventional fed-batch processes. This platform addresses the growing need for yield improvement, cost reduction, and environmental, social, and governance (ESG) considerations in bioprocess development.
Bioprocessing Technology Market Competitive Analysis Of Leading Industry Participants
Major companies operating in the bioprocessing technology market report areThermo Fisher Scientific Inc., Sartorius AG, Merck KGaA, Danaher Corporation, Lonza Group AG, GE Healthcare, Waters Corporation, STADA Arzneimittel AG, Bio-Rad Laboratories Inc., Applikon Biotechnology B.V., Agilent Technologies Inc., Solida Biotech GmbH, Fujifilm Healthcare Corporation, Catalent Inc., Asahi Kasei Medical Inc., Amgen Inc., Eppendorf AG, Repligen Corporation, Becton Dickinson and Company, MilliporeSigma, Novasep, Boehringer Ingelheim GmbH, Cytiva AB, Wuxi Biologics, AGC Biologics, Samsung Biologics, AbbVie Inc., Bristol Myers Squibb Company, Pfizer Inc., Roche Holding AG
View The Full Bioprocessing Technology Market Report:
Bioprocessing Technology Market Geographic Spread And Regional Opportunities
North America was the largest region in the bioprocessing technology market in 2025. The regions covered in the bioprocessing technology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.